Australia’s Therapeutic Goods Administration (TGA) has reinforced its warning to health professionals about the risk of suicidality associated with Straterra, after receiving reports of serious adverse events, including one case of completed suicide, two reports of attempted suicide, and 74 reports of psychiatric disorders associated with the drug. A study of children and adolescents found a .4% risk of suicide among 1357 patients, compared with a 0% risk in 851 patients treated with placebo.
Australian Government Department of Health, Therapeutic Goods Administration Medicines Safety Update. Australian Prescriber. 4(5) October, 2013
Of further interest:
Medicines Update (Pharmacy News)